# Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa

> **NCT04128683** · EARLY_PHASE1 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 31 (actual)

## Conditions studied

- Anorexia Nervosa

## Interventions

- **DRUG:** amisulpride
- **DRUG:** bromocriptine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04128683
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-20
- **Primary completion:** 2023-09-06
- **Final completion:** 2025-01-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2025-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04128683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04128683, "Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04128683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*